Knowing When to Use Stereotactic Ablative Radiation Therapy in Oligometastatic Cancer

Knowing When to Use Stereotactic Ablative Radiation Therapy in Oligometastatic Cancer

Davide Franceschini,1 Maria Ausilia Teriaca,1 Luca Dominici,1 Ciro Franzese,1,2 Marta Scorsetti1,2 1Department of Radiotherapy and Radiosurgery, IRCCS Humanitas Research Hospital, Milan, Italy; 2Department of Biomedical Sciences, Humanitas University, Milan, ItalyCorrespondence: Maria Ausilia Teriac...

Full description

Bibliographic Details
Main Authors: Franceschini D, Teriaca MA, Dominici L, Franzese C, Scorsetti M
Format: Article
Language:English
Published: Dove Medical Press 2021-09-01
Series:Cancer Management and Research
Subjects:
stereotactic ablative radiation therapy - oligometastases – prognostic factors – selection criteria
Online Access:https://www.dovepress.com/knowing-when-to-use-stereotactic-ablative-radiation-therapy-in-oligome-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/knowing-when-to-use-stereotactic-ablative-radiation-therapy-in-oligome-peer-reviewed-fulltext-article-CMAR

Similar Items